{"disease":{"id":"covert-hepatic-encephalopathy","name":"covert hepatic encephalopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06367127","title":"Utility of the Clamping Bean Test (CBT) for Covert Hepatic Encephalopathy Screening","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT03585257","title":"HEAL STUDY (Hepatic Encephalopathy and Albumin Study)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Hunter Holmes Mcguire Veteran Affairs Medical Center","has_results":false},{"nct_id":"NCT03077217","title":"Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT05189834","title":"GELSECTAN® and Covert Hepatic Encephalopathy","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Consorci Sanitari de l'Alt Penedès i Garraf","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}